de Boer Esther - Department of Surgery, University Medical Center Groningen

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Development of Assays to Allow Personalized Dosing of CAD Patients with Sutimlimab

Kyra Gelderman,Angela Kamp, Kathelijn Verdeyen,Esther de Boer,Floris Loeff,Theo Rispens,Richard Pouw, Josephine Vos

EUROPEAN JOURNAL OF IMMUNOLOGY (2024): 96-96

引用0浏览0引用

Distinct Sites of Complement Activation and Regulation in the Tumor Microenvironment of Colorectal Cancer

Joanne van Keulen, Julie Alles,Esther de Boer,Gerard van Mierlo,Angela Kamp,Mark Hoogenboezem, Liudmila Kodach,Jan Paul de Boer,Taco Kuijpers,Richard Pouw

EUROPEAN JOURNAL OF IMMUNOLOGY (2024): 223-223

引用0浏览0引用

Supplementary Figure 4 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts,Maximillian Koch,Johannes S. de Jong,Arthur L.L. Adams,Jürgen Glatz,Mariëtte E.G. Kranendonk,Anton G.T. Terwisscha van Scheltinga,Liesbeth Jansen, Jakob de Vries, Marjolijn N. Lub-de Hooge, Carolien P. Schröder,Annelies Jorritsma-Smit,Matthijs D. Linssen,Esther de Boer, Bert van der Vegt, Wouter B. Nagengast, Sjoerd G. Elias, Sabrina Oliveira,Arjen J. Witkamp,Willem P.Th.M. Mali, Elsken Van der Wall, Paul J. van Diest, Elisabeth G.E. de Vries,Vasilis Ntziachristos, Gooitzen M. van Dam

openalex（2023）

引用0浏览0引用

Supplementary Video 1 from Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer

Eben L. Rosenthal,Lindsay S. Moore,Kiranya Tipirneni,Esther de Boer,Todd M. Stevens,Yolanda E. Hartman,William R. Carroll,Kurt R. Zinn,Jason M. Warram

openalex（2023）

引用0浏览0引用

Supplementary Figure 2 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts,Maximillian Koch,Johannes S. de Jong,Arthur L.L. Adams,Jürgen Glatz,Mariëtte E.G. Kranendonk,Anton G.T. Terwisscha van Scheltinga,Liesbeth Jansen,Jakob de Vries,Marjolijn N. Lub-de Hooge, Carolien P. Schröder,Annelies Jorritsma-Smit,Matthijs D. Linssen,Esther de Boer, Bert van der Vegt, Wouter B. Nagengast, Sjoerd G. Elias, Sabrina Oliveira,Arjen J. Witkamp,Willem P.Th.M. Mali, Elsken Van der Wall,Paul J. van Diest, Elisabeth G.E. de Vries,Vasilis Ntziachristos, Gooitzen M. van Dam

openalex（2023）

引用0浏览0引用

Supplementary Figure 3 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

openalex（2023）

引用0浏览0引用

Supplemental Material and Methods from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

openalex（2023）

引用0浏览0引用

Supplementary Video 1 from Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

Eben L. Rosenthal,Jason M. Warram,Esther de Boer,Thomas K. Chung,Melissa L. Korb,Margie Brandwein-Gensler,Theresa V. Strong,Cecelia E. Schmalbach,Anthony B. Morlandt,Garima Agarwal,Yolanda E. Hartman,William R. Carroll,Joshua S. Richman,Lisa K. Clemons,Lisle M. Nabell,Kurt R. Zinn

openalex（2023）

引用0浏览0引用

Supplemental Figures 1 - 3 from Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn